Story
Goldman Sachs Private Credit Fund Fulfills All Q2 Withdrawal Requests, Bucking Industry Trend

Summary
Goldman Sachs Private Credit Corp. met 100% of investor withdrawal requests in the second quarter, a stark contrast to competitors like Blackstone and KKR who have limited redemptions amid a challenging high-rate environment.
Goldman Sachs's private credit fund fully honored all investor withdrawal requests for the second quarter, a notable exception to an industry-wide trend where major competitors have been forced to limit redemptions.
Full Redemptions Met
In a recent regulatory filing, the firm disclosed that its Goldman Sachs Private Credit Corp. (GSBD) fulfilled 100% of the $729 million in redemption requests it received for the period. This performance comes as the non-traded business development company (BDC) also reported a 4.3% return for the quarter.
This marks the second consecutive quarter that GSBD has met all withdrawal requests since its launch.
A Contrasting Industry Picture
Goldman's move stands in stark contrast to the broader private credit market, where elevated interest rates have prompted investors to seek liquidity, leading to a surge in withdrawal requests. Many of the largest funds in the space have been unable to meet this demand in full.
AdKey competitors have recently capped investor redemptions:
- Blackstone's BCRED, the largest fund in the sector, satisfied only 25% of its $1.3 billion in redemption requests in its most recent quarter.
- KKR's KCSL fulfilled 81% of the $231 million sought by its investors.
Context and Outlook
GSBD is a relatively new entrant, having launched in October 2023. Its smaller size compared to behemoths like Blackstone's BCRED may provide it with greater flexibility in managing its liquidity to meet investor outflows.
The fund successfully raised $1.5 billion within its first six months, indicating strong initial demand. For wealth managers and investors, a fund's ability to consistently honor redemptions is becoming a critical differentiating factor in the increasingly competitive private credit landscape.
Read next
More on Stocks
Dyne Therapeutics Shares Rise on Positive 12-Month Data for DM1 Drug
The clinical-stage biotech company reported significant functional improvements in patients with myotonic dystrophy type 1 (DM1) in its Phase 1/2 ACHIEVE trial, boosting investor confidence.

Accelevation Prices IPO at $18 Per Share Ahead of Nasdaq Debut
Accelevation Holdings Corp. has priced its initial public offering of 30 million shares at $18.00 each, with the majority of shares being sold by existing stockholders. The company is set to begin trading on the Nasdaq under the ticker ACCV.

TSA to Remove Chairs from Airport ID Checkpoints, Drawing Union Criticism
The Transportation Security Administration will require its officers to stand while checking IDs at US airports, a move the agency says enhances security but a major union decries as a disregard for worker safety.

Robinhood to Introduce 24/7 Trading with Weekend Access for Select US Stocks
The online brokerage announced it will allow users to trade a selection of US stocks and ETFs around the clock on weekends, a first for the platform and part of a broader industry shift toward continuous market access.